Show Summary Details

Page of

PRINTED FROM OXFORD HANDBOOKS ONLINE (www.oxfordhandbooks.com). © Oxford University Press, 2018. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Handbooks Online for personal use (for details see Privacy Policy and Legal Notice).

date: 16 December 2019

Abstract and Keywords

Dialectical Behaviour Therapy (DBT) is an internationally recognized evidence-based treatment for adults and adolescents reporting multiple problem behaviours related to emotion dysregulation. For clinical interventions, particularly DBT, the randomized controlled trial (RCT) is recognized as the ‘gold standard’ approach to testing effectiveness and efficacy. However, RCTs vary greatly in the rigorousness of research conducted. RCTs assessing DBT’s effectiveness have proliferated since the first published trial in 1994. DBT has been tested for diverse clinical presentations, in different formats, and focused on a variety of outcomes. The plethora of RCT research conducted, which vary in research design, clinician training and adherence among other factors, can make a clear interpretation of findings difficult. As a result, it can be unclear what is known about the effectiveness of DBT, and what is not. This review provides a summary and comprehensive critique of DBT RCTs to date, evaluates research quality assurance, and aims to identify and refine the current knowledge on DBT efficacy and effectiveness, along with areas of future research.

Keywords: randomized controlled trial, dialectical behaviour therapy, quality assurance, adherence, training, borderline personality disorder

Access to the complete content on Oxford Handbooks Online requires a subscription or purchase. Public users are able to search the site and view the abstracts and keywords for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can''t find the answer there, please contact us.